In 2023, Varda sent a pharma manufacturing capsule into space to test a crystallisation process for HIV therapy ritonavir, a ...

The FDA has called a plan to publish certain complete response letters (CRLs) for medicines it has rejected after an initial ...

Toymaker Mattel has launched its latest addition to the Barbie range of dolls, the first with type 1 diabetes, which comes ...

Looking back over the past five years, it's clear that healthcare professionals (HCPs) have faced incredible pressure and ...

The three-stage framework below guides organisations through their agentic AI journey, ensuring effective ecosystem ...

"Despite this decision of the Court of Justice, the European Commission continues to refuse to make the messages public," ...

New Evidation CEO Leslie Olay Wilberforce speaks at a Reuters event earlier this year. Earlier this year, San Francisco-based ...

A series of adverts for weight-loss services have been banned by the Advertising Standards Authority in the UK for promoting ...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Greg Piefer, founder and CEO of SHINE Technologies, a ...

The new data from the US Measles Tracker, hosted by the International Vaccine Access Center (IVAC) at the Johns Hopkins ...

After months of preparation and a drip-feed of some of its key features, the UK government has raised the curtain on its new 10-year plan for the NHS. The three over-arching themes are already ...

Health technology assessment (HTA) agency NICE has published final draft guidance for IL-23 inhibitor Omvoh (mirikizumab), ...